Skip to main content
Clinical Trials/JPRN-UMIN000053134
JPRN-UMIN000053134
Not yet recruiting
未知

A multicenter retrospective study to evaluate the efficacy and safety of platinum-based chemotherapy in combination with immunotherapy for extensive-stage small cell lung cancer in the real-world setting - Efficacy and safety of combination-immunotherapy for ES-SCLC

Shinshu University0 sites350 target enrollmentJanuary 20, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
extensive-stage small cell lung cancer
Sponsor
Shinshu University
Enrollment
350
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2024
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who are judged by the attending doctor as inappropriate to participate in this clinical research

Outcomes

Primary Outcomes

Not specified

Similar Trials